Core Insights - A joint research team from China and the U.S. has identified a key hub that drives lung cancer progression, leading to tumor cell diversity and treatment resistance, which could pave the way for fundamentally suppressing tumor evolution and achieving complete tumor eradication [1][2] Group 1: Research Findings - The research was conducted by a team led by Professor Yan Yan from Huazhong Agricultural University and Professor Tuomas Tammela from the Memorial Sloan Kettering Cancer Center, and the results were published in the journal Nature [1] - The team developed a novel genetic reporting system that allows for precise in-situ marking, longitudinal lineage tracing, and targeted specific elimination of certain tumor cell states, effectively equipping tumor cells with a "trackable chip" and a "targeted elimination switch" [1][2] Group 2: High Plasticity Cell States - The research identified a cell population termed "high plasticity cell states," which acts as a "traffic hub" within tumors, enabling differentiation into various tumor cell types and allowing previously differentiated cells to "recycle" under specific conditions, thus maintaining tumor heterogeneity and evolutionary potential [2] - Early elimination of "high plasticity cell states" can effectively block the progression of tumors to malignant stages, while targeting these cells in late-stage tumors can significantly inhibit tumor growth [2] - Residual "minimal lesions" that lead to recurrence after clinical treatment primarily originate from the "high plasticity cell states," and targeting these cells in conjunction with conventional chemotherapy or targeted drugs can nearly achieve complete tumor eradication [2]